MALIGNANT MELANOMA OF SITES OTHER THAN SKIN

This adverse event was reported 51 times

These drugs are most commonly taken by patients reporting MALIGNANT MELANOMA OF SITES OTHER THAN SKIN:

# Drug Count
0 INFLIXIMAB 7
1 PREDNISONE 4
2 ADALIMUMAB 3
3 ADALIMUMAB-AATY 3
4 ADALIMUMAB-ADAZ 3
5 ADALIMUMAB-FKJP 3
6 INTERFERON BETA-1A 3
7 LEVOTHYROXINE SODIUM 3
8 NATALIZUMAB 3
9 ALPRAZOLAM 2
See all common drugs associated with MALIGNANT MELANOMA OF SITES OTHER THAN SKIN

MALIGNANT MELANOMA OF SITES OTHER THAN SKIN is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 APRACLONIDINE 1 0.0090
1 OSPEMIFENE 1 0.0004
2 ACARBOSE 1 0.0003
3 LORLATINIB 1 0.0001
4 MESNA INJECTION 1 0.0001
5 MESNA 1 0.0001
6 PYRAZINAMIDE 1 0.0001
7 DABRAFENIB 2 0.0001
8 IFOSFAMIDE FOR INJECTION 2 0.0001
9 PREDNISOLONE ACETATE 1 0.0001
See all drugs enriched for association with MALIGNANT MELANOMA OF SITES OTHER THAN SKIN

MALIGNANT MELANOMA OF SITES OTHER THAN SKIN is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1 0.0015
1 Estrogen Agonist/Antagonist [EPC] 1 0.0004
2 alpha-Glucosidase Inhibitor [EPC] 1 0.0002
3 Influenza A M2 Protein Inhibitor [EPC] 1 0.0001
4 Integrin Receptor Antagonist [EPC] 5 0.0001
5 Bile Acid [EPC] 1 0.0000
6 Aluminum Complex [EPC] 1 0.0000
7 Antimycobacterial [EPC] 1 0.0000
8 Prostacyclin Receptor Agonist [EPC] 1 0.0000
9 Alkaloid [EPC] 1 0.0000
See all drug classes enriched for association with MALIGNANT MELANOMA OF SITES OTHER THAN SKIN